This year in January, the FDA approved DermaSensor, a real-time non-invasive skin cancer triage system. It is developed in collaboration between Case Western Reserve University and Zynamics GmbH, for use in non-dermatology offices. This walk-around portable instrument uses non-invasive photometric imaging and computational algorithms. It can identify precarious moles or patches and provides the patient with a snap prognosis of ...